ATRT-38. TAK228 COMBINES WITH NAVITOCLAX TO ENHANCE PLATINUM-INDUCED CYTOTOXICITY IN AT/RT

Jeffrey Rubens(Johns Hopkins University), Eric H. Raabe(Johns Hopkins University), Sabrina Wang(Johns Hopkins Medicine), Charles G. Eberhart(The University of Texas MD Anderson Cancer Center), Smit Shah(NYU Langone Health), Shreya Sharma(Institute of Bioinformatics and Applied Biotechnology), Kathy Warren(National Cancer Institute)
Neuro-Oncology
June 1, 2018
Cited by 0


Related Papers